MedTech Funding Mandate

In collaboration with Accelerated Access Collaborative (AAC) and The Health Innovation Network.

The NHS Long Term Plan committed to accelerate the uptake of selected innovative medical devices, diagnostics and digital products to patients faster, by developing the MedTech Funding Mandate policy, which is delivered in partnership with the Health Innovation Networks.

The MedTech Funding Mandate policy launch was delayed due to the COVID-19 pandemic. It was launched on the 1 April 2021. The guidance for 2022/23 is published here.

In 2021/22 the policy will support devices, diagnostics or digital products that:

  • are effective: demonstrated through positive NICE guidance;
  • deliver material savings to the NHS: the benefits of the innovation are over £1 million over five years for the population of England;
  • are cost-saving in-year: NICE modelling demonstrates a net saving in the first 12 months of implementing the technology;
  • are affordable to the NHS: the budget impact should not exceed £20 million, in any of the first three years.

To minimise burden on the NHS at this time, it was agreed that for the first year of the policy only, technologies must have also been previously supported by the Innovation Technology Payment.

The technologies that will be supported by the policy during 2022/2023 are:

Technology: BPH Group

The GreenLight XPS™ Laser Therapy System is a 180W, 532nm wavelength laser for the treatment of benign prostatic hyperplasia (BPH).

GreenLight XPS

Laser treatment restores dignity and quality of life

PLASMA+ System.

PLASMA

Patients enjoy benefits of wound-sealing technology

The Rezum system.

Rezum

Steam proves powerful remedy for prostate patients

Urolift device

UroLift

Easing patient anxiety with a quick prostate procedure

For more information on the Technology: BPH Group products, please contact: Cath Barrow, Senior Programme Development Lead, Delivery and Development Team at Health Innovation Manchester, or Craig Dobson, Project Manager at Health Innovation Manchester.

Products for improving the patient experience during procedures

XprESS multi‑sinus dilation system.

XprESS

XprESS multi‑sinus dilation system (XprESS, Entellus Medical)

Thopaz+device, with tubing, connecter and a fluid canister.

Thopaz+

Digital Chest Drainage and Monitoring System

The Spectra Optia system.

Spectra Optia

Spectra Optia Apheresis System

For more information on the products for improving the patient experience during procedures, please contact: Cath Barrow, Senior Programme Development Lead, Delivery and Development Team at Health Innovation Manchester, or Maryam Aziz, Programme Development Lead, Delivery & Development Team at Health Innovation Manchester.

Back to top